• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives 2-halopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Halopyridines 2-halopyridines

Recent Advances in the Application of 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (CAS: 458532-86-0) in Chemical Biology and Pharmaceutical Research

The compound 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (CAS: 458532-86-0) has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This boronic ester derivative is particularly valued for its role in Suzuki-Miyaura cross-coupling reactions, which are pivotal in the synthesis of complex organic molecules, including pharmaceuticals and agrochemicals. Recent studies have highlighted its utility in the development of novel therapeutic agents, especially in the fields of oncology and infectious diseases.

One of the most notable applications of this compound is its use as a key intermediate in the synthesis of tyrosine kinase inhibitors (TKIs). TKIs are a class of drugs that target specific signaling pathways involved in cancer progression. Researchers have successfully employed 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine in the construction of pyridine-based scaffolds, which are essential for the binding affinity and selectivity of these inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in the synthesis of a new generation of EGFR inhibitors, showing promising results in preclinical trials against non-small cell lung cancer (NSCLC).

Beyond oncology, this compound has also been explored in the context of antimicrobial drug development. Its boronic ester moiety facilitates the formation of stable complexes with bacterial enzymes, making it a valuable tool in the design of novel antibiotics. A recent study in Bioorganic & Medicinal Chemistry Letters reported the use of 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine in the synthesis of boron-containing analogs of existing antibiotics, which exhibited enhanced activity against drug-resistant strains of Staphylococcus aureus.

In addition to its pharmaceutical applications, this compound has been instrumental in chemical biology for the development of probes and sensors. Its ability to form reversible covalent bonds with diols and other nucleophiles has been leveraged in the design of fluorescent probes for detecting reactive oxygen species (ROS) in cellular environments. A 2022 publication in Chemical Communications detailed the use of this compound in a novel ROS-sensitive probe, which provided real-time monitoring of oxidative stress in live cells, offering new insights into the mechanisms of oxidative damage in neurodegenerative diseases.

The synthesis and scalability of 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine have also been subjects of recent research. Advances in catalytic systems and reaction conditions have improved the yield and purity of this compound, making it more accessible for large-scale pharmaceutical production. A 2023 review in Organic Process Research & Development highlighted innovative approaches to its synthesis, including the use of palladium-based catalysts and microwave-assisted reactions, which significantly reduce reaction times and environmental impact.

In conclusion, 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (CAS: 458532-86-0) continues to be a cornerstone in chemical biology and pharmaceutical research. Its multifaceted applications, from drug development to diagnostic tools, underscore its importance in advancing both basic science and clinical applications. Future research is expected to further explore its potential in emerging areas such as targeted drug delivery and personalized medicine, solidifying its role as a critical building block in modern chemistry.

• 1072945-00-6(2,6-Difluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 181219-01-2(4-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 444120-95-0(2-fluoro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 452972-14-4(2-Fluoropyridine-3-boronic acid, pinacol ester)
• 1150561-78-6(3-Bromo-2-fluoropyridine-4-boronic Acid Pinacol Ester)
• 1256358-86-7(2,5-Difluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1204333-58-3(2,6-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1218789-90-2(2,6-Difluoropyridine-3,5-diboronic acid, pinacol ester)
• 1146615-89-5(2-Chloro-6-fluoropyridine-4-boronic Acid Pinacol Ester)
• 755027-42-0(2-fluoro-5-methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine)